HC Wainwright Reaffirms Buy Rating for Denali Therapeutics (NASDAQ:DNLI)
HC Wainwright reaffirmed their buy rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a research report released on Wednesday, Benzinga reports. HC Wainwright currently has a $95.00 price target on the stock. HC Wainwright also issued estimates for Denali Therapeutics’ Q2 2024 earnings at ($0.63) EPS, Q3 2024 earnings at ($0.63) EPS, […]
More Stories
Love is Blind Couple, Chelsea and Kwame are Separating After 4 years Together
Yes, you heard it right. The famous couple from season 4 of Love is Blind is parting ways. The couple...
Netflix’s Romantic Drama, Forever Season 2 is Returning
Forever starring Lovie Simone is returning for its second season soon. Want to know more about the series details? Keep...
Popular Movies of Jason Momoa Movies on Netflix
Want to watch the older but popular movies of Jason Momoa? Here, in this blog, I have mentioned some of...
Netflix’s 10 Best Documentaries in 2026 That You Must Watch
There are tons of documentaries released in the blink of an eye in 2026. All these documentaries are based on...
Jason Biggs and Jenny Mollen Split After 18 Years of Marriage
Shocking news! Jason and his wife, Mollen, have separated after almost two decades together. What happened to the famous Hollywood...
Why Does Netflix Remove Shows? List of Shows Being Removed in 2026
Curious, why does Netflix remove shows from its library? There are several points that Netflix keeps in mind while removing...